Recent Analyst Forecasts and Stock Ratings
Seres Therapeutics, Inc. FAQ's
Seres Therapeutics, Inc. has been rated by research analysts at Chardan Capital in the past 90 days.
Seres Therapeutics, Inc. has been rated by research analysts at Chardan Capital in the past 90 days.